M.L. Richard Yip
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions
Papers in
-
- Natural product bioactivities and synthesis 3
- Protein Tyrosine Phosphatases 2
- PI3K/AKT/mTOR signaling in cancer 2
- Oncology 5
- Chemokine receptors and signaling 2
- Co-authors
- Nicholas J. Lawrence (4 shared papers)Saı̈d M. Sebti (4 shared papers)Harshani R. Lawrence (4 shared papers)Wayne C. Guida (4 shared papers)James Turkson (3 shared papers)Khandaker Siddiquee (1 shared paper)Richard Jove (1 shared paper)Benjamin Greedy (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (2 papers)Proceedings of the National Academy of Sciences (2 papers)Molecular Cancer Therapeutics (1 paper)Molecular Oncology (1 paper)Cancer Letters (1 paper)
- Partner nations
- United StatesAustraliaNew Zealand
In The Last Decade
M.L. Richard Yip
15 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Toxicology 88
- Oncology 591
- Immunology 359
- Molecular Biology 837
- Cancer Research 132
Countries citing papers authored by M.L. Richard Yip
This map shows the geographic impact of M.L. Richard Yip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.L. Richard Yip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.L. Richard Yip more than expected).
Fields of papers citing papers by M.L. Richard Yip
This network shows the impact of papers produced by M.L. Richard Yip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.L. Richard Yip. The network helps show where M.L. Richard Yip may publish in the future.
Co-authors
The 25 scholars most cited alongside M.L. Richard Yip, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity Hit paper breakdown → | 2007 | 616 |
| 2 | 2006 | 236 | |
| 3 | 1997 | 87 | |
| 4 | 2008 | 81 | |
| 5 | 2014 | 75 | |
| 6 | 2013 | 65 | |
| 7 | 2012 | 62 | |
| 8 | 2012 | 57 | |
| 9 | 2015 | 26 | |
| 10 | 2015 | 23 | |
| 11 | 2009 | 22 | |
| 12 | 2015 | 20 | |
| 13 | 2011 | 15 | |
| 14 | 2019 | 13 | |
| 15 | 2018 | 6 |
About M.L. Richard Yip
M.L. Richard Yip is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pharmacology and Immunology, having authored 15 papers that have together received 1.4k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (3 papers), Protein Tyrosine Phosphatases (2 papers), Galectins and Cancer Biology (2 papers), Phytochemistry and Biological Activities (2 papers), Flavonoids in Medical Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Marine Sponges and Natural Products (2 papers) and Chemokine receptors and signaling (2 papers). The work is most often cited by research in Toxicology (88 citations), Oncology (591 citations), Immunology (359 citations), Molecular Biology (837 citations) and Cancer Research (132 citations). M.L. Richard Yip has collaborated with scholars based in United States, Australia and New Zealand. Frequent co-authors include Nicholas J. Lawrence, Saı̈d M. Sebti, Harshani R. Lawrence, Wayne C. Guida, James Turkson, Khandaker Siddiquee, Richard Jove, Benjamin Greedy, Shumin Zhang and Michelle A. Blaskovich. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Proceedings of the National Academy of Sciences, Molecular Cancer Therapeutics, Molecular Oncology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.